Detalles de la búsqueda
1.
Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
Bioorg Chem;
100: 103955, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32464405
2.
Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis - a medicinal chemist perspective.
RSC Adv;
10(61): 37098-37115, 2020 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35521286
3.
Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents.
RSC Adv;
10(21): 12272-12288, 2020 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35497605
4.
Correction: Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents.
RSC Adv;
10(32): 18907, 2020 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35518313
5.
Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
Chem Biol Drug Des;
91(6): 1078-1086, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29063733
6.
Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.
Eur J Med Chem;
87: 71-8, 2014 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25240097
7.
Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues.
Eur J Med Chem;
84: 605-13, 2014 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25062011
Resultados
1 -
7
de 7
1
Próxima >
>>